Scarica l'app Stockscreener
327.64
0.10%
0.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN - MarketBeat
Mattern Capital Management LLC Buys 4,411 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Miracle Mile Advisors LLC - MarketBeat
Pullback Watch: Is Amgen Inc AMG0 stock worth holding before Fed meetingWeekly Trend Recap & Stock Market Timing Techniques - moha.gov.vn
Braun Stacey Associates Inc. Has $1.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Hofer & Associates. Inc - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Ascent Group LLC - MarketBeat
Amgen Inc (TSX:AMGN) Stock News, Headlines & Updates - GuruFocus
Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC - MarketBeat
Boston Trust Walden Corp Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings? - TradingView — Track All Markets
Strong Results and Pipeline Momentum Power Amgen's (AMGN) 2025 Rally - Finviz
Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally - Insider Monkey
Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch - ts2.tech
Can Amgen's MariTide Take on Leaders in the Obesity Space? - The Globe and Mail
Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Argus Adjusts Price Target on Amgen to $360 From $310, Maintains Buy Rating - marketscreener.com
Diversified Trust Co Has $12.05 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
The Truth About Amgen Inc.: Is This Biotech Giant the Next Big Money Gamechanger? - AD HOC NEWS
Amgen Inc.: How a Biotech Veteran Is Rebuilding Its Flagship Pipeline - AD HOC NEWS
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus - ts2.tech
Strong results and pipeline momentum power Amgen’s (AMGN) 2025 rally - MSN
Verastem ends trial of Avmapki Fakzynja combo with Amgen's Lumakras in NSCLC - Seeking Alpha
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc. - MarketBeat
Amgen Inc. Stock (AMGN) Opinions on 2025 Revenue Guidance and Drug Sales - Quiver Quantitative
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
Carnegie Investment Counsel Has $30.27 Million Stake in Amgen Inc. $AMGN - MarketBeat
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Check out Amgen's stock price (AMGN-CA) in real time - CNBC
Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc. - MarketBeat
Avanza Fonder AB Purchases 4,546 Shares of Amgen Inc. $AMGN - MarketBeat
Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)? - simplywall.st
Brookstone Capital Management Acquires 16,042 Shares of Amgen Inc. $AMGN - MarketBeat
Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC - MarketBeat
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know - The Globe and Mail
Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - MarketBeat
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd. - MarketBeat
Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail
Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat
Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat
Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech
Fitch upgrades Amgen to ’BBB+’ on improved financial structure By Investing.com - Investing.com Nigeria
Fitch upgrades Amgen to ’BBB+’ on improved financial structure - Investing.com
Fitch raises Amgen credit rating, outlook stable - breakingthenews.net
Our Workforce - Amgen
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025 - ts2.tech
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors - TipRanks
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease - TipRanks
Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease - MSN
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025) - ts2.tech
Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements - simplywall.st
The Best Dividend ETF to Buy: SCHD Pays a High Yield While VIG Focuses on Dividend Growth - The Motley Fool
0.93%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):